Additionally, the Inflation Reduction Act of 2022 includes several provisions such as drug pricing controls and Medicare redesign that are likely to impact our business to varying degrees, but its ultimate effect on our business and the healthcare industry in general is not yet known
All entries for: CAMP4 Therapeutics
April 30, 2025
CAMP4 Therapeutics
Neutral Outlook
Cambridge, MA
51-200 employees
Disease Area: Cardiology, Metabolic Diseases, Multiple, Neurological Diseases, Rare Diseases
Drug Type: Small Molecule